Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 17, 2016
Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects
Peter N Morcos, Li Yu, Katrijn Bogman, et al.
British Journal of Clinical Pharmacology
|
October 11, 2018
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
Stefan Sturm, Andreas Günther, Birgit Jaber, et al.
Neuromuscular Disorders : NMD
|
December 17, 2018
The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy
Heidemarie Kletzl, Anne Marquet, Andreas Günther, et al.
Bioanalysis
|
November 18, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS)
Jan Welink, Eric Fluhler, Nicola Hughes, et al.
The AAPS Journal
|
June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teams
Eric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 17, 2016
Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects
Peter N Morcos, Li Yu, Katrijn Bogman, et al.
British Journal of Clinical Pharmacology
|
October 11, 2018
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier
Stefan Sturm, Andreas Günther, Birgit Jaber, et al.
Neuromuscular Disorders : NMD
|
December 17, 2018
The oral splicing modifier RG7800 increases full length survival of motor neuron 2 mRNA and survival of motor neuron protein: Results from trials in healthy adults and patients with spinal muscular atrophy
Heidemarie Kletzl, Anne Marquet, Andreas Günther, et al.
Bioanalysis
|
November 18, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 1 - small molecules by LCMS)
Jan Welink, Eric Fluhler, Nicola Hughes, et al.
The AAPS Journal
|
June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teams
Eric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Page
of 4